Man Group »

4d Molecular Therapeutics In shares owned by Man Group

Quarter-by-quarter ownership of 4d Molecular Therapeutics In (FDMT) shares owned by Man Group from 13F filings

Historical chart of Man Group investment in 4d Molecular Therapeutics In

Tip: Access up to 7 years of quarterly data

All positions including 4d Molecular Therapeutics In held by Man Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in 4d Molecular Therapeutics In by Man Group

Quarter filed Position value Share count Share price at filing
2025-09-30 $161k 19k 8.69
2025-06-30 $501k 135k 3.71
2025-03-31 $168k 52k 3.23
2022-09-30 $391k 49k 8.03
2022-06-30 $121k 17k 6.95

More positions owned by Man Group

NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Apple (AAPL)
Amazon (AMZN)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Alphabet Cap Stk Cl A (GOOGL)
Meta Platforms Cl A (META)
Broadcom (AVGO)
Tesla Motors (TSLA)
Mastercard Incorporated Cl A (MA)
Alphabet Cap Stk Cl C (GOOG)
Adobe Systems Incorporated (ADBE)
Bristol Myers Squibb (BMY)
Costco Wholesale Corporation (COST)
Boston Scientific Corporation (BSX)

View all positions for Man Group

Top funds holding 4d Molecular Therapeutics In

BVF
RA Capital Management
Goldman Sachs Group
BlackRock
Vanguard Group
Novo A/S
Henderson Group
Federated Investors
Millennium Management
Armistice Capital
Morgan Stanley
Geode Capital Management
State Street Corporation
Assenagon Asset Management
Two Sigma Advisers

View all funds holding 4d Molecular Therapeutics In